HCWB Reports $1.2M Revenue, $0.05 EPS, Exercises Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen
HCW Biologics Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $1.98
-19% in 1d after detection
Post-detection moves
1h
+5.4%
1d
-19%
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS